News | Heart Failure | April 12, 2022

Comedian Gilbert Gottfried Dies After Battle With Recurrent Ventricular Tachycardia

In an official statement from his family, Gilbert Gottfried, the comedian with the memorable voice, died today at age 67 reportedly following a long-term illness, Recurrent Ventricular Tachycardia due to Myotonic Dystrophy type II.  

Image of late comedian Gilbert Gottfried from Wikipedia


April 12, 2022 — In an official statement from his family, Gilbert Gottfried, the comedian with the memorable voice, died today at age 67 reportedly following a long-term illness, Recurrent Ventricular Tachycardia due to Myotonic Dystrophy type II.  

Tachycardia refers to a heart rate that’s too fast. Ventricular tachycardia is a fast heart rate that starts in the heart’s lower chambers (ventricles). This type of arrhythmia may be either well-tolerated or life-threatening, requiring immediate diagnosis and treatment.

According to the NIH, "Myotonic dystrophy type 2, one of the two types of myotonic dystrophy, is an inherited muscular dystrophy that affects the muscles and other body systems (e.g., heart, eyes, and pancreas)."

For more information: www.heart.org


Related Content

News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
News | Heart Failure

March 8, 2024 — The Texas Heart Institute, Georgia Institute of Technology (Georgia Tech), North Carolina State ...

Home March 08, 2024
Home
News | Heart Failure

March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2 ...

Home March 05, 2024
Home
Subscribe Now